Top compounds associated with response to MAGEC2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.03
mRNA pandacostat CTRPv2 pan-cancer AAC -0.078 0.04
mRNA ABT-199 CTRPv2 pan-cancer AAC -0.094 0.04
mRNA Gefitinib GDSC1000 pan-cancer AAC -0.069 0.04
mRNA JW-7-24-1 GDSC1000 pan-cancer AAC -0.062 0.04
mRNA CAL-101 CTRPv2 pan-cancer AAC -0.075 0.04
mRNA CGP-60474 GDSC1000 pan-cancer AAC 0.11 0.04
mRNA FK866 GDSC1000 pan-cancer AAC -0.064 0.04
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC -0.089 0.04
mRNA AM-580 CTRPv2 pan-cancer AAC -0.076 0.04
Download CSV